AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

AstraZeneca made a big commitment to China as CEO Pascal Soriot joined British Prime Minister Keir Starmer on a trip to the ...

The Trump administration is delaying the release of TrumpRx, an online platform that lets people buy prescription drugs ...

By Bharath Rajeswaran Feb 1 (Reuters) - Indian benchmarks held on to modest gains in a special trading session on Sunday as ...

A living evidence approach treats evidence as shared infrastructure rather than as a series of isolated projects.

GLP-1 therapies helped drive a 79% year-over-year increase in strategic pharmaceutical M&A deal value through mid-November ...

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

Manufacturers are pushing for higher prices overseas, but face political and economic resistance.

Sun Pharmaceutical Industries Inc. and its subsidiary Taro Pharmaceuticals USA Inc. gained final approval of a $200 million antitrust deal to settle claims they conspired with other drugmakers to ...

Novo spent almost $500M on advertising GLP-1s in the U.S. last year; Pharma companies keep spending on weight-loss drug ...

The Danish pharma giant teased its presence at the Big Game via several social media posts. Actress Danielle Brooks, best ...